Rising investment and focus on stem cell research, increasing demand for cell-based therapeutics, and high prevalence of chronic and infectious disease globally are key factors driving market growth The global cell viability assays market size is expected to reach USD 6.35 Billion by 2028 at a CAGR of 8.7%, according to the latest report by Reports and Data. Growing...